Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1ACT-385781A (Actelion Epoprostenol)[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
2Current marketed FLOLAN (epoprostenol sodium)[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
3EPOPROSTENOL[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
4Epoprostenol for injection[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
5EPOPROSTENOL SODICO[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
6EPOPROSTENOL SODIUM[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
7Epoprostenol-Actelion[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
8Epoprostenolo per iniezione----[1] 86 💬
9New thermo stable formulation of epoprostenol sodium[1] Epoprostenol[1] Epoprostenol 💬[1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬